YouTube & Expert Fact Checks
YouTube claims compared with clinical data.
Popular videos about retatrutide and GLP-1 drugs fact-checked claim-by-claim against published clinical trial data. When the video gets something right, we show the receipts. When it doesn’t, we show that too.
Browse fact checks
17 articles
Adrian Crook Quit Retatrutide After 6 Months: What He Learned
A personal account checked against trial evidence, with self-reported outcomes separated from verified drug effects.
Updated September 8, 2026
Andrew Huberman on Retatrutide: What He Said and What the Data Shows
Huberman called retatrutide 'the peptide that changes everything.' Here's what he said and what the data actually shows.
Updated September 9, 2026
Coach Colin Watson on Retatrutide: 12-Week Review vs What the Data Shows
Colin Watson’s retatrutide account checked against trial evidence on muscle loss, side effects and weight regain, with transcript and commercial-interest limits.
Updated September 8, 2026
Coach Gary Miller on Retatrutide: His Protocol vs What the Data Shows
Gary Miller's retatrutide protocol fact-checked against Phase 2 and Phase 3 clinical data.
Updated September 8, 2026
Dave Knapp on CagriSema vs Tirzepatide, Novo Nordisk's Triple Agonist UBT-251, and Retatrutide: Fact Check
Dave Knapp’s CagriSema, UBT251 and pricing coverage: accurate headline figures, with unproven patient-selection and strategy claims distinguished.
Updated September 8, 2026
David DeMesquita's Retatrutide Injection Guide: What He Shows and What You Should Know
What DeMesquita’s injection demonstration establishes, and why it is not a validated retatrutide protocol.
Updated September 8, 2026
Dr. Alex Tatem on Retatrutide: A Physician's Breakdown Fact-Checked
A physician's retatrutide explainer fact-checked — mechanism, Phase 2 data, drug comparisons, and FDA timeline.
Updated September 8, 2026
Dr. Amin Hedayat on Retatrutide: What the Data Shows
The evidence behind Hedayat’s liver, cardiac, muscle and anhedonia claims.
Updated September 8, 2026
Dr. Ashley Froese on Retatrutide: Why It's the "King" of Fat Loss Peptides, Fact-Checked
A physician's retatrutide explainer fact-checked — GIP futile calcium cycling, glucagon thermogenesis, muscle loss, allodynia, and dosing.
Updated September 8, 2026
Dr. Dan on Retatrutide vs Ozempic: Obesity Expert Fact Check
Dr. Dan’s retatrutide claims checked against Phase 2 evidence and later trial updates.
Updated September 8, 2026
Dr. Jones DC on Retatrutide: Trial Results and Food Chatter Claims
Trial results, personal observations and unvalidated add-ons in Dr. Jones DC’s retatrutide video.
Updated September 8, 2026
Dr. Kevin Joseph on Retatrutide: Physician's Overview Fact-Checked
What Joseph’s retatrutide overview gets right and which proposed benefits remain unproven.
Updated September 8, 2026
JD Denham on Retatrutide: Triple Agonist Mechanism, Dosing, and Fat Loss Claims — Fact Check
Peptide of the Week hosts on retatrutide dosing, nausea, muscle loss, and fat burning — fact-checked against clinical data.
Updated September 8, 2026
Michael Morelli on Retatrutide: Fact Check
The original video was unavailable. This update assesses the recorded medical claims without verifying attribution or assigning an overall video accuracy rating.
Updated September 8, 2026
NBC TODAY on Foundayo (Oral GLP-1 Pill): Fact Check
TODAY’s Foundayo segment checked against FDA information, with the automated drug-name discrepancy kept separate from verified claims.
Updated September 8, 2026
Nick Trigili on Retatrutide: His 10-Week Protocol vs What the Data Shows
His reported experience and trial commentary assessed separately; the transcript’s dropout wording is internally inconsistent.
Updated September 8, 2026
The Peptide Advantage and Retatrutide: What the Trial Evidence Can Check
Source video unavailable. Independent trial evidence on dosing and combinations, without attributed claim verdicts.
Updated September 8, 2026
How we fact-check
- Transcript. We pull the full video transcript and extract every factual claim — weight loss percentages, dosing schedules, mechanism descriptions, safety assertions, comparisons to other drugs.
- Source. Each claim is checked against primary sources: peer-reviewed journals (NEJM, Lancet, JAMA), the trial registration on ClinicalTrials.gov, and the sponsor’s press releases and regulatory filings.
- Verdict per claim. We label each claim as supported, partially correct, misleading, or contradicted — and link to the underlying source.
- Context. Where the creator oversimplifies or adds context not in the trial, we flag it and add what the data actually shows.
Who gets reviewed
We focus on voices people are actively watching: physicians (Drs. Alex Tatem, Kevin Joseph, Dr. Dan), coaches and bodybuilding figures (Gary Miller, Nick Trigili, David DeMesquita, Colin Watson, Michael Morelli), podcasters (Andrew Huberman), and peptide-focused creators (JD Denham, Dave Nap, The Peptide Advantage).
Each review is structured the same way — creator’s strongest claim, weakest claim, and overall accuracy read. Search the directory above for a creator or topic.
Reviews are editorial, not legal or medical advice. If we get a fact-check wrong ourselves, reach out via about and we’ll update.